Spot Trading’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-31,900
Closed -$286K 3573
2016
Q3
$286K Buy
31,900
+12,000
+60% +$85.3K 0.01% 1856
2016
Q2
$107K Hold
19,900
﹤0.01% 2514
2016
Q1
$92K Sell
19,900
-260,700
-93% -$1.05M ﹤0.01% 2612
2015
Q4
$1.46M Buy
280,600
+167,600
+148% +$972K 0.02% 1208
2015
Q3
$684K Buy
113,000
+14,600
+15% +$179K 0.01% 1845
2015
Q2
$1.55M Sell
98,400
-81,300
-45% -$988K 0.01% 1307
2015
Q1
$1.95M Sell
179,700
-2,000
-1% -$20.4K 0.02% 1143
2014
Q4
$1.91M Buy
181,700
+78,600
+76% +$768K 0.01% 1424
2014
Q3
$989K Buy
103,100
+23,100
+29% +$236K ﹤0.01% 2093
2014
Q2
$924K Buy
+80,000
New +$728K ﹤0.01% 2197

Spot Trading's RPTP Position: Q4 2016 in Review

Spot Trading sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 15,452 shares — an estimated $139K sold.

Spot Trading first reported a position in RPTP in Q2 2014 and held it in 10 quarters. The position peaked at $2.32M in Q2 2014. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Spot Trading reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 15,452 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $139K.
  • Spot Trading first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2014 and held it in 10 quarters.
  • Spot Trading's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.32M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.